Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-24

Clinical Trial Update: Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial is evaluating a phytoestrogen extract from Pueraria mirifica for improving serum lipid parameters in postmenopausal women, with Phase 2 and Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pueraria mirifica phytoestrogen extract (phytoestrogen from Pueraria mirifica)

Snippet

Sponsor: Dhurakij Pundit University | Conditions: Dyslipidemias, Hypertriglyceridemia | Phase 2, Phase 3 | Status: RECRUITING